These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25712794)

  • 41. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility and molecular epidemiology of clinical Enterobacter cloacae bloodstream isolates in Shanghai, China.
    Wang S; Xiao SZ; Gu FF; Tang J; Guo XK; Ni YX; Qu JM; Han LZ
    PLoS One; 2017; 12(12):e0189713. PubMed ID: 29244831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study.
    Enoch DA; Brown F; Sismey AW; Mlangeni DA; Curran MD; Karas JA; Cone DB; Aliyu SH; Dhanji H; Doumith M; Maharjan S; Meunier D; Woodford N
    J Hosp Infect; 2012 Aug; 81(4):270-7. PubMed ID: 22742987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Japan: emergence of CTX-M-15-producing E. coli ST131.
    Kuroda H; Yano H; Hirakata Y; Arai K; Endo S; Kanamori H; Yamamoto H; Ichimura S; Ogawa M; Shimojima M; Komatsu M; Jonai T; Itagaki S; Nonomiya Y; Suwabe A; Kaku M
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):201-3. PubMed ID: 22796185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China.
    Yu Y; Ji S; Chen Y; Zhou W; Wei Z; Li L; Ma Y
    J Infect; 2007 Jan; 54(1):53-7. PubMed ID: 16533535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Cho SY; Kang CI; Cha MK; Wi YM; Ha YE; Chung DR; Lee NY; Peck KR; Song JH;
    Microb Drug Resist; 2015 Aug; 21(4):463-9. PubMed ID: 25756854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia.
    Shin J; Kim DH; Ko KS
    J Infect; 2011 Jul; 63(1):39-47. PubMed ID: 21712135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
    Kang CI; Cha MK; Kim SH; Ko KS; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    J Korean Med Sci; 2013 Jul; 28(7):998-1004. PubMed ID: 23853481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia.
    Yasir M; Ajlan AM; Shakil S; Jiman-Fatani AA; Almasaudi SB; Farman M; Baazeem ZM; Baabdullah R; Alawi M; Al-Abdullah N; Ismaeel NA; Shukri HA; Azhar EI
    Sci Rep; 2018 Oct; 8(1):14847. PubMed ID: 30287889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of antimicrobial resistance rates and phylogenetic groups of community-acquired versus hospital-acquired invasive Escherichia coli.
    Ferjani S; Saidani M; Amine FS; Boutiba Ben Boubaker I
    Med Mal Infect; 2015 Apr; 45(4):133-8. PubMed ID: 25725924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases.
    Mushtaq S; Irfan S; Sarma JB; Doumith M; Pike R; Pitout J; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2002-5. PubMed ID: 21669947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.
    Rodríguez I; Figueiredo AS; Sousa M; Aracil-Gisbert S; Fernández-de-Bobadilla MD; Lanza VF; Rodríguez C; Zamora J; Loza E; Mingo P; Brooks CJ; Cantón R; Baquero F; Coque TM
    mSphere; 2021 Dec; 6(6):e0086821. PubMed ID: 34935444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.
    Franiczek R; Sobieszczańska B; Turniak M; Kasprzykowska U; Krzyzanowska B; Jermakow K; Mokracka-Latajka G
    Adv Clin Exp Med; 2012; 21(2):187-92. PubMed ID: 23214282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial -Escherichia coli infection in China.
    Shi H; Sun F; Chen J; Ou Q; Feng W; Yong X; Xia P
    Ann Clin Microbiol Antimicrob; 2015 Jan; 14():4. PubMed ID: 25591816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.